In a reader survey, researchers and core lab staff share how they think cores are doing.
Researchers are working on RNA inference-based pesticides for crops, according to Digital Trends.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.
Researchers from the Broad Institute and Novartis used RNA interference to generate catalogs of genes that cancer cells rely on to grow and survive.
The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.
Researchers described the development and testing of layered double hydroxide nanosheets as carriers for RNAi molecules in agriculture.
An Australian team has developed a method to spray double-stranded RNA on plants to make them resistant to pests, Technology Review reports.
The researchers said their one-step, inducible, multiplex gene knockdown and gene knockout platforms can be used in many differentiated cell types.
In PLOS this week: sites in dog genome under selection during early domestication, tuberculosis transmission patterns, and more.
A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.
Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.
NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.
In Science this week: environmental DNA can help in studies of marine animals, and more.